ES536743A0 - Un procedimiento para la preparacion de arilindan-1,3-dionas. - Google Patents

Un procedimiento para la preparacion de arilindan-1,3-dionas.

Info

Publication number
ES536743A0
ES536743A0 ES536743A ES536743A ES536743A0 ES 536743 A0 ES536743 A0 ES 536743A0 ES 536743 A ES536743 A ES 536743A ES 536743 A ES536743 A ES 536743A ES 536743 A0 ES536743 A0 ES 536743A0
Authority
ES
Spain
Prior art keywords
arilindan
dionas
procedure
preparation
arylindane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES536743A
Other languages
English (en)
Other versions
ES8602582A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of ES536743A0 publication Critical patent/ES536743A0/es
Publication of ES8602582A1 publication Critical patent/ES8602582A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33Polycyclic acids
    • C07C63/331Polycyclic acids with all carboxyl groups bound to non-condensed rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/67Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16Unsaturated compounds
    • C07C61/39Unsaturated compounds containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pens And Brushes (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
ES536743A 1983-10-14 1984-10-11 Un procedimiento para la preparacion de arilindan-1,3-dionas. Expired ES8602582A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838327598A GB8327598D0 (en) 1983-10-14 1983-10-14 Pharmacologically active diarylindane-13-diones

Publications (2)

Publication Number Publication Date
ES536743A0 true ES536743A0 (es) 1985-11-16
ES8602582A1 ES8602582A1 (es) 1985-11-16

Family

ID=10550228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536743A Expired ES8602582A1 (es) 1983-10-14 1984-10-11 Un procedimiento para la preparacion de arilindan-1,3-dionas.

Country Status (16)

Country Link
US (1) US4569945A (es)
EP (1) EP0138272B1 (es)
JP (1) JPS60109541A (es)
KR (1) KR920003101B1 (es)
AT (1) ATE32214T1 (es)
AU (1) AU561309B2 (es)
CA (1) CA1245232A (es)
DE (1) DE3469020D1 (es)
DK (1) DK491984A (es)
ES (1) ES8602582A1 (es)
FI (1) FI82923C (es)
GB (1) GB8327598D0 (es)
GR (1) GR80629B (es)
HU (1) HUT35627A (es)
PT (1) PT79356B (es)
ZA (1) ZA847967B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556966B1 (fr) * 1983-12-26 1987-09-25 Bouchard Sa Laboratoires Nouvelle application therapeutique d'un derive de l'indane dione et les compositions pharmaceutiques destinees a cet usage
FR2593501B1 (fr) * 1986-01-29 1988-05-06 Panmedica Sa Nouveaux derives bis (r-oxyimino)-5,7 dihydro-6,7 (5h) dibenzo (a,c) cycloheptene, leurs procedes de preparation et leur application comme medicaments
JP2582898B2 (ja) * 1989-05-16 1997-02-19 三菱化学株式会社 インダン―1,3―ジオン誘導体およびこれを有効成分とする除草剤
PT2722322T (pt) 2011-06-16 2019-09-27 Univ Leuven Kath Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral
ES2863985T3 (es) 2012-12-14 2021-10-13 Korea Res Inst Chemical Tech Nuevo compuesto, sal farmacéuticamente aceptable o isómero óptico del mismo, método para prepararlo y composición farmacéutica para la prevención o el tratamiento de enfermedades virales que lo contienen como ingrediente activo
JP7592748B2 (ja) 2020-04-20 2024-12-02 ノバルティス アーゲー 抗ウイルス1,3-ジ-オキソ-インデン化合物
US12083092B2 (en) 2020-04-20 2024-09-10 Novartis Ag Antiviral 1,3-di-oxo-indene compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2361517A (en) * 1939-09-22 1944-10-31 Gen Electric Sealing apparatus
DE947473C (de) * 1953-04-30 1956-08-16 Geigy Ag J R Verfahren zur Herstellung von 2-(p-Chlorphenyl)-indan-1, 3-dion
DE1130439B (de) * 1960-06-27 1962-05-30 Us Vitamin Pharm Corp Verfahren zur Herstellung von 2-Arylindandionen
BE668871A (es) * 1964-08-27
GB1172696A (en) * 1966-10-20 1969-12-03 Koninklijke Pharma Fab Nv Phenyl-Indandione Derivatives
US3784606A (en) * 1968-08-29 1974-01-08 Pfizer Novel 2-aryl-1,3-indandiones and 2-aryl-2,3-dihydrobenz(f)indene-1,3-diones
US3879468A (en) * 1969-04-14 1975-04-22 Union Carbide Corp 2-(poly substituted phenyl)-1,3-indandione compounds
US3803240A (en) * 1969-04-14 1974-04-09 Union Carbide Corp 2-(2,6-substituted-phenyl)-1,3-indandiones
US3784605A (en) * 1971-05-13 1974-01-08 Union Carbide Corp 2-(polysubstituted phenyl)-1,3-indandione compounds
GB1380089A (en) * 1972-01-20 1975-01-08 Istituto Gentilipisa Spa 2-aryl-1,3-indandiones
US3978231A (en) * 1972-01-25 1976-08-31 Beecham Group Limited Pharmaceutical compositions and method of treating allergic conditions utilizing 2-nitroindane-1,3-dione derivatives as the active agents
US3976681A (en) * 1973-10-12 1976-08-24 Merck & Co., Inc. [1,3-Dioxo-2-substituted and 2,2-disubstituted- indanyloxy (or thio] alkanoic acids
FR2392951A2 (fr) * 1975-02-07 1978-12-29 Creat Lab Nouveaux derives de la ninhydrine, leurs procedes de preparation et medicaments contenant ces derives

Also Published As

Publication number Publication date
AU3418484A (en) 1985-04-18
ZA847967B (en) 1985-05-29
GR80629B (en) 1985-02-12
PT79356B (en) 1986-09-08
GB8327598D0 (en) 1983-11-16
EP0138272B1 (en) 1988-01-27
PT79356A (en) 1984-11-01
AU561309B2 (en) 1987-05-07
US4569945A (en) 1986-02-11
KR920003101B1 (ko) 1992-04-18
HUT35627A (en) 1985-07-29
FI82923B (fi) 1991-01-31
ES8602582A1 (es) 1985-11-16
ATE32214T1 (de) 1988-02-15
DK491984A (da) 1985-04-15
CA1245232A (en) 1988-11-22
KR850003382A (ko) 1985-06-17
EP0138272A1 (en) 1985-04-24
FI82923C (fi) 1991-05-10
JPS60109541A (ja) 1985-06-15
DE3469020D1 (en) 1988-03-03
DK491984D0 (da) 1984-10-12
FI844020A0 (fi) 1984-10-12
FI844020L (fi) 1985-04-15

Similar Documents

Publication Publication Date Title
AR241120A1 (es) Procedimiento para la homopolimerizacion de isopreno
ES519559A0 (es) Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.
ES536743A0 (es) Un procedimiento para la preparacion de arilindan-1,3-dionas.
BG37992A3 (bg) Метод за получаване на производни на бензамида
AR220383A1 (es) Procedimiento para la preparacion de 2,3,5,6-tetracloropiridina y pentacloropiridina
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
SE8500845D0 (sv) Forfarande for framstellning av glyoxylylspermidin och anvendningen derav for framstellning av 15-deoxispergualin-beslektade foreningar
AR210888A1 (es) Procedimiento para la preparacion de nuevas benzamidas 2,4-disustituidas,2,5-disustituidas y 2,4,5-trisustituidas
IT1133044B (it) Procedimento per la riduzione della stabilita' termica del caglio microbico
ES538806A0 (es) Procedimiento para la obtencion de nuevos 1,4-naftoquinonderivados
IT1062619B (it) Procedimento ed impianto per la depurazione di-stillativa di 2.5 diosso i ossa 2 fosfolani
BR8100480A (pt) Composicoes inseticidas, processo para sua preparacao e processo para o tratamento de vegetais
ES2021692B3 (es) Procedimiento para la fabricacion de n-(sulfonilmetil) formamidas e isocianuros de sulfonilmetilo.
IT7925203A0 (it) Procedimento per il trattamento di correnti effluenti contenenti nitrofenoli.
ES555599A0 (es) Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico
ATE52917T1 (de) Kombinationspraeparat.
AR223223A1 (es) Procedimiento para la preparacion de bis-(p-(i-etoxi-etoxi)fenil)-2-piridilmetano(i)
ES523637A0 (es) Procedimiento para preparar un nonapeptido.
DE2960856D1 (en) Substituted n-halogenomethyl anilides, process for their preparation and use
IL57838A (en) Process for the preparation of o-methyl-n-cyclohexyl-2,5-dimethyl-furan-3-hydroxamic acid,n-cyclohexyl-n-methoxyacetoacetamide employed as intermediate therein and its preparation
ES549271A0 (es) Procedimiento para la obtencion del metilsulfato de 4-amino-6-metoxi-1-fenilpiridazinio
ES532121A0 (es) Procedimiento para la obtencion del metilsulfato de 4-amino-6-metoxi-1-fenilpiridazinio
ES534849A0 (es) Procedimiento para la obtencion industrial de cuadros
AR220221A1 (es) Procedimiento para la produccion de un articulo de vermiculita,composicion que lo contiene y dicho articulo
SU1075674A1 (ru) 2,3,2,3-Тетрагидро-3,3-тетрацианметилен-5,5-бис-as-триазин, обладающий противовоспалительной и анальгетической активностью

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303